Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomed Res Int ; 2019: 7453260, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31781640

RESUMO

The body's autoimmune process is involved in the development of Graves' disease (GD), which is manifested by an overactive thyroid gland. In some patients, autoreactive inflammatory reactions contribute to the development of symptoms such as thyroid ophthalmopathy, and the subsequent signs and symptoms are derived from the expansion of orbital adipose tissue and edema of extraocular muscles within the orbit. The autoimmune process, production of antibodies against self-antigens such as TSH receptor (TSHR) and IGF-1 receptor (IGF-1R), inflammatory infiltration, and accumulation of glycosaminoglycans (GAG) lead to edematous-infiltrative changes in periocular tissues. As a consequence, edema exophthalmos develops. Orbital fibroblasts seem to play a crucial role in orbital inflammation, tissue expansion, remodeling, and fibrosis because of their proliferative activity as well as their capacity to differentiate into adipocytes and myofibroblasts and production of GAG. In this paper, based on the available medical literature, the immunological mechanism of GO pathogenesis has been summarized. Particular attention was paid to the role of orbital fibroblasts and putative autoantigens. A deeper understanding of the pathomechanism of the disease and the involvement of immunological processes may give rise to the introduction of new, effective, and safe methods of treatment or monitoring of the disease activity.


Assuntos
Autoantígenos/imunologia , Fibroblastos/imunologia , Oftalmopatia de Graves/imunologia , Adipócitos/patologia , Adipogenia , Tecido Adiposo , Citocinas/metabolismo , Fibroblastos/patologia , Oftalmopatia de Graves/patologia , Oftalmopatia de Graves/terapia , Humanos , Ácido Hialurônico/metabolismo , Inflamação/imunologia , Desenvolvimento Muscular , Músculos Oculomotores , Órbita/patologia , Receptor IGF Tipo 1 , Receptores da Tireotropina/imunologia , Glândula Tireoide/patologia
2.
Biomed Res Int ; 2019: 1628029, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31915681

RESUMO

Exosomes, the smallest vesicles (30-100 nm) among multivesicular bodies, are released by all body cells including tumor cells. The cargo they transfer plays an important role in intercellular communication. Tumor-derived exosomes (TEXs) maintain interactions between cancer cells and the microenvironment. Emerging evidence suggests that tumor cells release a large number of exosomes, which may not only influence proximal tumor cells and stromal cells in the local microenvironment but can also exert systemic effects as they are circulating in the blood. TEXs have been shown to boost tumor growth promote progression and metastatic spread via suppression or modification of the immune response towards cancer cells, regulation of tumor neo-angiogenesis, pre-metastatic niche formation, and therapy resistance. In addition, recent studies in patients with cancer suggest that TEXs could serve as tumor biomarker reflecting partially the genetic and molecular content of the parent cancer cell (i.e., as a so-called "liquid biopsy"). Furthermore, recent studies have demonstrated that exosomes may have immunotherapeutic applications, or can act as a drug delivery system for targeted therapies with drugs and biomolecules.


Assuntos
Exossomos , Neoplasias , Biomarcadores Tumorais , Progressão da Doença , Humanos , Células Neoplásicas Circulantes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...